Back
Ginkgo Bioworks Holdings Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Sell
45
DNA
Ginkgo Bioworks Holdings
Last Price:
9.44
Seasonality Move:
-37.29%
Sell
34
LXRX
Lexicon Pharmaceuticals
Last Price:
0.82
Seasonality Move:
2.58%
Sell
45
Ginkgo Bioworks Holdings (DNA)
is a Sell
Is Ginkgo Bioworks Holdings a Buy, Sell or Hold?
- The current Ginkgo Bioworks Holdings [DNA] share price is $9.44. The Score for DNA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- DNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $0.81. The Score for LXRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DNA Stock Price Chart
What is Ginkgo Bioworks Holdings's stock price today?
-
The Ginkgo Bioworks Holdings share price today is $9.44
The current trend is moderately bullish and DNA is experiencing selling pressure, which indicates risk of future bearish movement.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $0.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 52.26 | Buy |
| Chaikin Money Flow: | -1056113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.11 - 10.27) | Buy |
| Bollinger Bands (100): | (6.57 - 10.81) | Buy |
LXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 40.15 | Sell |
| Chaikin Money Flow: | 4061878 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 1.04) | Sell |
| Bollinger Bands (100): | (1.08 - 1.94) | Sell |
DNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.49 | Sell |
| 20-day SMA: | 8.78 | Buy |
| 50-day SMA: | 8.41 | Buy |
| 200-day SMA: | 19.42 | Sell |
| 8-day EMA: | 10.1 | Sell |
| 20-day EMA: | 9.38 | Buy |
| 50-day EMA: | 8.89 | Buy |
| 200-day EMA: | 20.54 | Sell |
LXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Buy |
| 20-day SMA: | 0.8 | Buy |
| 50-day SMA: | 1.29 | Sell |
| 200-day SMA: | 1.72 | Sell |
| 8-day EMA: | 0.79 | Buy |
| 20-day EMA: | 0.87 | Sell |
| 50-day EMA: | 1.15 | Sell |
| 200-day EMA: | 1.58 | Sell |
Ginkgo Bioworks Holdings Earnings Growth & DNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.47 per share, and an increase next year of $0.03 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.20 per share.
Ginkgo Bioworks Holdings Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lexicon Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||